Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,085 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Saito M, Nose H, Usuku K, Sabouri AH, Matsuzaki T, Izumo S, Arimura K, Osame M. Saito M, et al. Among authors: matsuzaki t. J Neurol Sci. 2006 Jul 15;246(1-2):37-43. doi: 10.1016/j.jns.2006.02.004. Epub 2006 Mar 6. J Neurol Sci. 2006. PMID: 16545396
Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus load.
Nose H, Saito M, Usuku K, Sabouri AH, Matsuzaki T, Kubota R, Eiraku N, Furukawa Y, Izumo S, Arimura K, Osame M. Nose H, et al. Among authors: matsuzaki t. J Neurovirol. 2006 Jun;12(3):171-7. doi: 10.1080/13550280600827336. J Neurovirol. 2006. PMID: 16877298
Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.
Saito M, Nakagawa M, Kaseda S, Matsuzaki T, Jonosono M, Eiraku N, Kubota R, Takenouchi N, Nagai M, Furukawa Y, Usuku K, Izumo S, Osame M. Saito M, et al. Among authors: matsuzaki t. J Infect Dis. 2004 Jan 1;189(1):29-40. doi: 10.1086/380101. Epub 2003 Dec 31. J Infect Dis. 2004. PMID: 14702150 Clinical Trial.
Inhibition of ABL1 tyrosine kinase reduces HTLV-1 proviral loads in peripheral blood mononuclear cells from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
Kodama D, Tanaka M, Matsuzaki T, Izumo K, Nakano N, Matsuura E, Saito M, Nagai M, Horiuchi M, Utsunomiya A, Takashima H, Kubota R, Izumo S. Kodama D, et al. Among authors: matsuzaki t. PLoS Negl Trop Dis. 2020 Jul 15;14(7):e0008361. doi: 10.1371/journal.pntd.0008361. eCollection 2020 Jul. PLoS Negl Trop Dis. 2020. PMID: 32667912 Free PMC article.
[Diagnosis and treatment of HAM].
Nakagawa M, Matsuzaki T, Kubota H, Osame M. Nakagawa M, et al. Among authors: matsuzaki t. Nihon Naika Gakkai Zasshi. 1998 Apr 10;87(4):648-54. doi: 10.2169/naika.87.648. Nihon Naika Gakkai Zasshi. 1998. PMID: 9627473 Review. Japanese. No abstract available.
1,085 results